Granules India Limited today, announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Metoprolol Succinate Extended-Release Tablets USP, 25 mg, 50 mg, 100 mg and 200 mg, the company announced through an exchange filing. It is bioequivalent to the reference…Read More
Granules India Received ANDA Approval For Metoprolol Succinate ER Tablets
